Search results
Earnings call: OMNIQ reports revenue growth and fintech expansion
Investing.com· 18 hours agoOMNIQ Corp (OTC: OMQS ) has announced a positive start to the year in their First Quarter 2024...
Roche stock jumps as obesity drug shows 'encouraging results' in Phase I trial By Investing.com
Investing.com· 14 hours agoRoche stock jumps as obesity drug shows 'encouraging results' in Phase I trial
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
Benzinga via Yahoo Finance· 4 hours agoThursday, Genentech, a unit of Roche Holdings AG (OTC:RHHBY), released results from the Phase 1b...
Walgreens launches own brand of opioid overdose reversal drug
Reuters via Yahoo Finance· 1 day agoU.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which would be available ...
Drug overdose deaths fell in 2023, 1st decrease in 5 years: CDC
ABC News· 1 day agoDrug overdose deaths fell in 2023, marking the first decrease in five years, new provisional federal...
...Marijuana, Markets, Legal Circuits And Compliance - Walgreens Boots Alliance (NASDAQ:WBA),...
Benzinga· 2 hours agoIn an exclusive interview with Benzinga Cannabis, Aaron Bloom, an attorney and CEO of DocMJ, a...
BenevolentAI and AstraZeneca discover novel heart failure target using AI
Proactive Investors· 2 days agoBenevolentAI (AMS:BAI, OTC:BAIVF) told investors it has reached an important milestone in its...
Noxopharm scales up production of lupus drug SOF-SKN™ to GLP standards
Proactive Investors· 3 days agoNoxopharm Ltd (ASX:NOX, OTC:NOXOF) has reached a major drug development milestone in scaling up...
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into...
WPRI Providence· 1 day ago(OTC: CATV) announced today the execution of a Letter of Intent (LOI) to acquire Genetic Networks, LLC (https://geneticnetworks.com/), a leader in applied molecular biology ...
Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences
Digital Journal· 6 hours agoPsycheceutical Bioscience, Inc. is developing cutting-edge technologies to advance the safe and effective delivery of therapeutic medicines. Powered by a team of FDA drug ...